Notice of dividend

RNS Number : 2886C

The MedicX Fund Limited

30 April 2012

 



For Immediate Release

30 April 2012

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Notice of dividend

The Directors have approved a quarterly dividend of 1.4p per ordinary share in respect of the period 1 January 2012 to 31 March 2012. The Directors expect, subject to unforeseen circumstances, to pay dividends totalling 5.6p per Ordinary Share in respect of the financial year ending 30 September 2012.  The dividend will be paid on 29 June 2012 to ordinary shareholders on the register as at 18 May 2012 (the "Record Date"). The corresponding ex-dividend date will be 16 May 2012. 

The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 29 June 2012, by participating in the Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010.

The option to participate will be available to shareholders until 8 June 2012 (the "election date").  Further information on the Scheme, together with a copy of the Scheme Document (which contains the terms and conditions of the Scheme) and relevant mandate form document, is available for inspection at the National Storage Mechanism (http://www.hemscott.com/nsm.do), or through the Scrip Dividend portal on the Company's website http://www.medicxfund.com/scrip).

End

For further information please contact:

MedicX Group
Keith Maddin, Chairman	[phone]
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Canaccord Genuity Limited
Andrew Zychowski/Helen Goldsmith	[phone]
Buchanan
Charles Ryland/Suzanne Brocks	[phone]
MedicX Fund Limited
David Staples, Chairman	[phone]

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 71 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 26 people operating across the UK.  

 The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

DIVMMGZDVNFGZZM